UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Expert opinion on drug safety, ISSN 1474-0338, 10/2020, Volume 19, Issue 10, pp. 1237 - 1250
Journal Article
Journal of headache and pain, ISSN 1129-2369, 12/2017, Volume 18, Issue 1, pp. 1 - 9
Cgrp receptor | Acute treatment | Cgrp | Gepants | Migraine | Prophylactic treatment | Neurology | Pain Medicine | Medicine & Public Health | Internal Medicine | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Animals | Receptors, Calcitonin Gene-Related Peptide - antagonists & inhibitors | Migraine Disorders - drug therapy | Humans | Calcitonin Gene-Related Peptide - antagonists & inhibitors | Drugs | Nervous system diseases | Care and treatment | Usage | Headache | Wound healing | Epilepsy | Socio-economic aspects | Central nervous system | Clinical trials | Mental depression | Calcitonin gene-related peptide | Pituitary | Calcitonin | Monoclonal antibodies | Cardiovascular diseases | Constipation | Long-term effects | Index Medicus | Neurologi | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin
Journal Article
Expert opinion on drug safety, 12/2020, pp. 1 - 8
Journal Article
Bone (New York, N.Y.), ISSN 8756-3282, 02/2021, Volume 143, pp. 115646 - 115646
Journal Article
European journal of pharmacology, ISSN 0014-2999, 06/2018, Volume 829, pp. 85 - 92
Journal Article
Journal of pain research, ISSN 1178-7090, 12/2017, Volume 10, pp. 2751 - 2760
Erenumab | CGRP receptor | Episodic migraine | CGRP | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Dosage and administration | Drug therapy | Migraine | Calcitonin | Risk factors | Immunoglobulins | Pain | Peptides | Headaches | Systematic review | Drug dosages | Veins & arteries
Journal Article
Peptides (New York, N.Y. : 1980), ISSN 0196-9781, 01/2021, Volume 135, pp. 170423 - 170423
Journal Article
Internal and emergency medicine, ISSN 1828-0447, 12/2016, Volume 11, Issue 8, pp. 1045 - 1057
Internal Medicine | Medicine & Public Health | Monoclonal antibodies against CGRP | CGRP | Migraine | Migraine prophylaxis | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Receptors, Calcitonin Gene-Related Peptide - drug effects | Antibodies, Monoclonal - therapeutic use | Migraine Disorders - drug therapy | Antibodies, Monoclonal - pharmacology | Humans | Pain Management - methods | Care and treatment | Pain | Peptides | Liver | Monoclonal antibodies | Medicine, Preventive | Preventive health services | Index Medicus
Journal Article
Headache, ISSN 0017-8748, 06/2019, Volume 59, Issue 6, pp. 951 - 970
CGRP receptor antagonist | calcitonin gene‐related peptide | migraine treatment | migraine prevention | CGRP receptor antibody | CGRP neutralizing antibody | calcitonin gene-related peptide | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Viral antibodies | Peptides | Migraine | Calcitonin | Genes | Antibodies | Drug therapy | Neuroimaging | Headache | Brain | Intravenous administration | Target recognition | Sumatriptan | Clinical trials | Drug development | Blood | Modulators | Fibers | Prevention | Receptors | Pain | Developmental stages | Occupancy | Sensory neurons | Tomography | Medical research | Effectiveness | Oral administration | Positron emission | Blood vessels | Pharmacology | Calcitonin gene-related peptide | Monoclonal antibodies | Positron emission tomography | Index Medicus
Journal Article